ArticleBMC surgery2026
Efficacy and safety of high-frequency electrosurgery, ultrasonic scalpel, and bipolar electrocoagulation in parathyroidectomy for secondary hyperparathyroidism: a 3-year follow-up retrospective study.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the surgical outcomes of parathyroidectomy (PTX) for secondary hyperparathyroidism (SHPT) in hemodialysis patients, comparing the use of three operative techniques: high-frequency electrosurgery (HFE), ultrasonic scalpel (US), and bipolar electrocoagulation (BPE).
methodsThe patients were divided into three groups based on the type of surgical instruments used. Outcomes assessed included surgical efficiency, postoperative complications, recurrence rate, hospitalization costs, biochemical and nutritional parameters over 1 year, and overall survival through March 2025.
resultsA total of 171 patients were retrospectively categorized into three groups: HFE (n = 50), US (n = 60), and BPE (n = 61). Compared to group HFE, both the US and BPE groups exhibited significantly shorter durations for drainage tube removal, operative times, and postoperative hospital stays (all p < 0.05). The BPE group also had significantly lower intraoperative blood loss compared to the US and HFE groups (p < 0.05) and incurred the lowest hospitalization costs. The incidence of postoperative complications and recurrence rates did not differ significantly among groups. All groups showed marked reductions in serum calcium, phosphorus, and intact parathyroid hormone levels postoperatively, which stabilized over time with no significant differences between groups. At the 1-year follow-up, patients exhibited significant improvements in anemia-related and nutritional markers compared to baseline. With follow-up extending to March 2025, overall survival did not differ significantly among the three surgical groups (p = 0.987).
conclusionsPTX effectively corrected SHPT, improved anemia, and enhanced nutritional status in hemodialysis patients. All three surgical techniques, HFE, US, and BPE, were safe and effective, with comparable long-term survival. However, US and BPE offered superior operative efficiency, and BPE represented the most cost-effective option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.